ExeGi Pharma distributes Visbiome, a high potency probiotic medical food intended for the dietary management of dysbiosis associated with irritable bowel syndrome, ulcerative colitis, pouchitis and hepatic encephalopathy. Visbiome offers a very high potency of bacteria ranging from 112.5 billion bacteria-900 billion bacteria, depending on the product. Visbiome is available in capsules, packets, and prescription-strength packets.
Brands: ExeGi Pharma
DDW Tracks Microbiome in Gastrointestinal and Liver Diseases, Inflammatory Bowel Diseases, Liver Diseases and Transplantation, Obesity and Nutrition, Esophageal Diseases, Stomach and Small Bowel Disorders, Colorectal Diseases, Functional GI and Motility Disorders, Pancreatic Diseases, Biliary Tract Diseases, Pediatric GI
Does your company only service US attendees? No
Is your company a new exhibiting company? No